Gene · 6391
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 18F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. | Liver Cancer | 2025 | 40242795 | PubTator, text mining | PubMed |
| SLC25A11, a Novel Gene Associated With Carney-Stratakis Syndrome. | J Endocr Soc | 2025 | 40242210 | PubTator, text mining | PubMed |
| A Mathematical Exploration of SDH-b Loss in Chromaffin Cells. | Bull Math Biol | 2025 | 40080323 | PubTator, text mining | PubMed |
| A Review of Genomic Testing and SDH- Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST. | Cancer Med | 2025 | 39927693 | PubTator, text mining | PubMed |
| Identification and validation of Atp5f1c in CD4+ T cell as a hub protein in Parkinson's disease. | Int J Biol Macromol | 2025 | 39814280 | PubTator, text mining | PubMed |
| Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis. | Exp Ther Med | 2025 | 39776888 | PubTator, text mining | PubMed |
| Renal cell carcinoma with succinate dehydrogenase A mutation: A case report and literature review. | Oncol Lett | 2025 | 39664613 | PubTator, text mining | PubMed |
| Similar deficiencies, different outcomes: succinate dehydrogenase loss in adrenal medulla vs. fibroblast cell culture models of paraganglioma. | Cancer Metab | 2024 | 39716277 | PubTator, text mining | PubMed |
| A New Efficient Explicit Deferred Correction Framework: Analysis and Applications to Hyperbolic PDEs and Adaptivity. | Commun Appl Math Comput | 2024 | 39669397 | PubTator, text mining | PubMed |
| Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer. | JCO Precis Oncol | 2024 | 39666927 | PubTator, text mining | PubMed |
| The role of methylation quantification of circulating tumor DNA (ctDNA) as a diagnostic biomarker of Pheochromocytomas (PCCs) and Paragangliomas (PGLs). | J Diabetes Metab Disord | 2024 | 39610555 | PubTator, text mining | PubMed |
| Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. | Cancers (Basel) | 2024 | 39594770 | PubTator, text mining | PubMed |
| Pheochromocytoma-Paraganglioma Syndrome: A Multiform Disease with Different Genotype and Phenotype Features. | Biomedicines | 2024 | 39457697 | PubTator, text mining | PubMed |
| Differential expression of nuclear-derived mitochondrial succinate dehydrogenase genes in metabolically active buffalo tissues. | Mol Biol Rep | 2024 | 39425877 | PubTator, text mining | PubMed |
| Psychometric properties of the social determinants of health questionnaire (SDH-Q): development and validation. | BMC Public Health | 2024 | 39285351 | PubTator, text mining | PubMed |
| Algorithm of genetic diagnosis for patients with head and neck paraganglioma-update. | Front Neurol | 2024 | 39268066 | PubTator, text mining | PubMed |
| The Complete Mitogenome of Apostasia fujianica Y.Li & S.Lan and Comparative Analysis of Mitogenomes across Orchidaceae. | Int J Mol Sci | 2024 | 39125719 | PubTator, text mining | PubMed |
| Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma. | Pathol Res Pract | 2024 | 39083879 | PubTator, text mining | PubMed |
| AutoDock and molecular dynamics-based therapeutic potential prediction of flavonoids for primary Sjögren's syndrome. | Heliyon | 2024 | 39027572 | PubTator, text mining | PubMed |
| Highly active repeat-mediated recombination in the mitogenome of the aquatic grass Hygroryza aristata. | BMC Plant Biol | 2024 | 38973002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6391/papers?page=6